NCT00942344View on ClinicalTrials.gov

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Hypertension
Interventions
DRUG

Amlodipine plus Losartan

amlodipine/losartan 5/50mg, 5/100mg, 10/50mg, 10/100mg

DRUG

Amlodipine

amlodipine 5mg, 10mg

DRUG

Losartan

Losartan 50mg, 100mg

Trial Locations (1)

Unknown

14 sites in Korea, Seoul, Busan, Etc.

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT00942344 - Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension | Biotech Hunter | Biotech Hunter